Further molecular mechanism investigation indicated that TXNDC5 was downregulated by decreasing m6A-levels after METTL3 knockdown and ultimately inhibiting the progression of primary acral melanoma. This evidence concerns the gene TXNDC5 and acral lentiginous melanoma.